Stay updated on Daratumumab for MRD Reappearance in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Related topics entries 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the page.
    Difference
    0.2%
    Check dated 2025-12-30T22:31:21.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a Locations section listing recruitment sites in Greater Poland Voivodeship and Masovian Voivodeship (Poland) as part of the v3.3.3 update.
    Difference
    0.3%
    Check dated 2025-12-23T22:06:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    The page revision was updated to v3.3.2, replacing the previous v3.2.0 in the revision history. This change does not affect study details or user-facing content.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:01.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The banner with government funding and operating status information at the top of the page has been removed.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:07.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now includes a link to related topics under MedlinePlus Genetics, and the 'Multiple Myeloma' topic is added to related topics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-03T21:17:28.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The related topics section no longer lists 'Multiple Myeloma' and 'MedlinePlus Genetics'. The primary study details and contact information remain unchanged.
    Difference
    0.2%
    Check dated 2025-10-27T20:35:39.000Z thumbnail image

Stay in the know with updates to Daratumumab for MRD Reappearance in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.